Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Envoy Medical Inc (COCH)

Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,224
  • Shares Outstanding, K 28,787
  • Annual Sales, $ 230 K
  • Annual Income, $ -20,800 K
  • EBIT $ -20 M
  • EBITDA $ -19 M
  • 60-Month Beta 2.10
  • Price/Sales 39.33
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.41
  • Most Recent Earnings $-0.35 on 11/10/25
  • Next Earnings Date 03/27/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +222,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3800 +27.76%
on 02/11/26
0.7300 -33.49%
on 01/12/26
-0.1941 (-28.56%)
since 01/09/26
3-Month
0.3800 +27.76%
on 02/11/26
0.8709 -44.25%
on 12/04/25
-0.2163 (-30.82%)
since 11/11/25
52-Week
0.3800 +27.76%
on 02/11/26
1.9100 -74.58%
on 05/14/25
-0.9845 (-66.97%)
since 02/11/25

Most Recent Stories

More News
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Enrollment momentum accelerates as Company advances toward full enrollmentWhite Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the...

COCH : 0.5099 (+30.78%)
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantagesWhite Bear Lake, Minnesota--(Newsfile Corp....

COCH : 0.5099 (+30.78%)
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focusWhite Bear Lake, Minnesota--(Newsfile...

COCH : 0.5099 (+30.78%)
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Event to Take Place December 11th at 4:30 P.M. ETWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health...

COCH : 0.5099 (+30.78%)
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Patent adds to Envoy Medical's expanding intellectual property portfolio, reinforcing the Company's leadership in next generation cochlear implant innovationWhite Bear Lake, Minnesota--(Newsfile Corp....

COCH : 0.5099 (+30.78%)
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

The trials expansion highlights the Company's clinical momentum and growing confidence in the device's adoption and Company's commercial strategyWhite Bear Lake, Minnesota--(Newsfile Corp. - November 18,...

COCH : 0.5099 (+30.78%)
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition,...

COCH : 0.5099 (+30.78%)
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Rapid patient enrollment underscores strong market interest and reinforces commercialization opportunity for fully implanted cochlear implantsWhite Bear Lake, Minnesota--(Newsfile Corp. - November 4, 2025)...

COCH : 0.5099 (+30.78%)
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

The Company looks to build on its recent momentum - receiving FDA approval to expand its pivotal clinical trial into the second and final stageWhite Bear Lake, Minnesota--(Newsfile Corp. - October 29,...

COCH : 0.5099 (+30.78%)
Envoy Medical Receives Positive Listing Determination from NASDAQ

White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...

COCH : 0.5099 (+30.78%)

Business Summary

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

See More

Key Turning Points

3rd Resistance Point 0.5001
2nd Resistance Point 0.4746
1st Resistance Point 0.4322
Last Price 0.5099
1st Support Level 0.3643
2nd Support Level 0.3388
3rd Support Level 0.2964

See More

52-Week High 1.9100
Fibonacci 61.8% 1.3255
Fibonacci 50% 1.1450
Fibonacci 38.2% 0.9645
Last Price 0.5099
52-Week Low 0.3800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar